PacificHealth Laboratories, Inc.
PHLI · OTC
9/30/2012 | 6/30/2012 | 3/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Market Cap | $3 | $4 | $4 | $3 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $4 | $4 | $3 |
| Revenue | $2 | $2 | $2 | $1 |
| % Growth | -22.8% | 27.3% | 81.2% | – |
| Gross Profit | $1 | $1 | $1 | $0 |
| % Margin | 34% | 38.9% | 42.5% | 38.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.2% | -1.9% | -1.4% | -49.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20.1% | -3.1% | -2.3% | -50.6% |
| EPS Diluted | -0.017 | -0.003 | -0.002 | -0.024 |
| % Growth | -403% | -73.7% | 92.1% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |